Literature DB >> 718280

A prospective study of gout in New Zealand Maoris.

G W Brauer, I A Prior.   

Abstract

Results are reported from the first prospective study of gout in New Zealand Maoris based on a sample of 388 males and 378 females. At baseline, high mean levels of serum uric acid (SUA) were found, 0.422 +/- 0.092 mmol/1 (7.05 +/- 1.54 mg/100 ml) in males and 0.350 +/- 0.091 mmol/1 (5.85 +/- 1.52 mg/100 ml) in females. On the basis of traditional criteria (SUA above 0.42 mmol/1 (7.0 mg/100 ml) in males and above 0.36 mmol/1 (6.0 mg/100 ml) in females) the prevalence of hyperuricaemia was 49% in males and 42% in females. The baseline prevalence of gout (8.8% for males and 0.8% for females) and the subsequent 11-year incidence rates (10.3% for males and 4.3% for females) are discussed in relation to specified SUA classes. When traditional, sex-specific criteria for hyperuricaemia were used, no relationship was found between the prevalence of hyperuricaemia and the incidence of gout. There was, however, a sharp increase in the incidence rate of gout in both sexes when SUA levels were above 0.48 mmol/1 (8.0 mg/100 ml). In subjects with a baseline SUA above this level, the age-standardised 11-year incidence rate of gout was 29.1% for males and 37.2% for females. A previously unreported relationship linking muscle size to the incidence of gout in males is presented as a major finding of the study. Other risk factors associated with gout were body mass and blood pressure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718280      PMCID: PMC1000277          DOI: 10.1136/ard.37.5.466

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  SERUM URIC ACID ESTIMATION CHEMICAL AND ENZYMATIC METHODS COMPARED.

Authors:  M J BUCHANAN; I C ISDALE; B S ROSE
Journal:  Ann Rheum Dis       Date:  1965-05       Impact factor: 19.103

2.  THE DISTRIBUTION OF SERUM URIC ACID VALUES IN A POPULATION UNSELECTED AS TO GOUT OR HYPERURICEMIA: TECUMSEH, MICHIGAN 1959-1960.

Authors:  W M MIKKELSEN; H J DODGE; H VALKENBURG
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

3.  Gout in the Maori.

Authors:  G A LENNANE; B S ROSE; I C ISDALE
Journal:  Ann Rheum Dis       Date:  1960-06       Impact factor: 19.103

4.  Current concepts of "normal values," "reference values," and "discrimination values," in clinical chemistry.

Authors:  F W Sunderman
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

5.  A health survey in a rural Maori community, with particular emphasis on the cardiovascular, nutritional and metabolic findings.

Authors:  I PRIOR
Journal:  N Z Med J       Date:  1962-07

6.  Serum uric acid in relation to age and physique in health and in coronary heart disease.

Authors:  M M GERTLER; S M GARN; S A LEVINE
Journal:  Ann Intern Med       Date:  1951-06       Impact factor: 25.391

7.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

8.  Gout with normal serum urate concentration.

Authors:  M L Snaith; E N Coomes
Journal:  Br Med J       Date:  1977-03-12

9.  Hyperuricaemia, gout, and diabetic abnormality in Polynesian people.

Authors:  I A Prior; B S Rose; H P Harvey; F Davidson
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

10.  Serum uric acid in England and Scotland.

Authors:  R A Sturge; J T Scott; A C Kennedy; D P Hart; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

View more
  15 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 2.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 3.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

4.  Migration and gout: the Tokelau Island migrant study.

Authors:  I A Prior; T J Welby; T Ostbye; C E Salmond; Y M Stokes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-22

5.  Gout is on the increase in New Zealand.

Authors:  P Klemp; S A Stansfield; B Castle; M C Robertson
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

6.  Association between high-sensitivity C-reactive protein and hyperuricemia.

Authors:  Tuo Yang; Xiang Ding; Yi-Lun Wang; Chao Zeng; Jie Wei; Hui Li; Yi-Lin Xiong; Shu-Guang Gao; Yu-Sheng Li; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2016-02-10       Impact factor: 2.631

Review 7.  EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; E Pascual; T Bardin; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

8.  Reference range of serum uric acid and prevalence of hyperuricemia: a cross-sectional study from baseline data of ELSA-Brasil cohort.

Authors:  Murillo Dório; Isabela M Benseñor; Paulo Lotufo; Itamar S Santos; Ricardo Fuller
Journal:  Adv Rheumatol       Date:  2022-05-08

9.  Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.

Authors:  Angelo L Gaffo; Kenneth G Saag
Journal:  Core Evid       Date:  2010-06-15

Review 10.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.